Lindsay Rutt

The paper examines vaginal microbiota, symptoms, and immune markers in transmasculine individuals on testosterone therapy, finding Lactobacillus dominance linked to adverse symptoms and inflammation.

This study examines the vaginal microbiome and immune markers before, during, and after metronidazole treatment for bacterial vaginosis, identifying distinct phases and highlighting the need for probiotics to maintain microbial balance.

This study introduces VIRGO2, an enhanced gene catalog for the vaginal microbiome, revealing new bacterial species, mycobiome features, and gene expression patterns.

This study identifies Prevotella as a major source of sialidases in the vaginal microbiome, showing their prevalence and activity compared to Gardnerella.

The paper shows that colonization with nonoptimal human cervicovaginal microbiota in mice leads to developmental issues and increased neonatal mortality.